Agilent Technologies (NYSE:A) Updates Q3 2026 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its third quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.480-1.500 for the period, compared to the consensus earnings per share estimate of 1.500. The company issued revenue guidance of $1.8 billion-$1.9 billion, compared to the consensus revenue estimate of $1.8 billion. Agilent Technologies also updated its FY 2026 guidance to 6.000-6.100 EPS.

Agilent Technologies Price Performance

Shares of NYSE:A traded up $0.74 during trading on Wednesday, reaching $115.82. The stock had a trading volume of 2,339,395 shares, compared to its average volume of 2,182,175. Agilent Technologies has a 52 week low of $108.35 and a 52 week high of $160.27. The business’s 50-day moving average price is $114.91 and its 200 day moving average price is $129.01. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. The stock has a market capitalization of $32.73 billion, a PE ratio of 25.57, a P/E/G ratio of 2.42 and a beta of 1.22.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter last year, the firm posted $1.31 EPS. The business’s revenue was up 7.0% on a year-over-year basis. As a group, equities analysts predict that Agilent Technologies will post 5.95 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.9%. Agilent Technologies’s payout ratio is presently 22.52%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on A. Barclays lowered their price objective on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Wells Fargo & Company lowered their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research report on Thursday, February 26th. Wall Street Zen lowered Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Robert W. Baird lifted their price objective on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research report on Tuesday. Finally, TD Cowen lowered their target price on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Two research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $162.40.

Hedge Funds Weigh In On Agilent Technologies

Several institutional investors have recently modified their holdings of the business. Fiduciary Trust Co lifted its holdings in shares of Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after purchasing an additional 77 shares in the last quarter. IHT Wealth Management LLC grew its stake in shares of Agilent Technologies by 4.9% in the fourth quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after buying an additional 96 shares in the last quarter. UMB Bank n.a. increased its holdings in shares of Agilent Technologies by 3.0% during the 4th quarter. UMB Bank n.a. now owns 4,500 shares of the medical research company’s stock worth $612,000 after acquiring an additional 131 shares during the last quarter. Zions Bancorporation National Association UT lifted its holdings in Agilent Technologies by 17.2% during the 4th quarter. Zions Bancorporation National Association UT now owns 990 shares of the medical research company’s stock valued at $135,000 after purchasing an additional 145 shares during the last quarter. Finally, Modern Wealth Management LLC lifted its holdings in Agilent Technologies by 5.7% during the 2nd quarter. Modern Wealth Management LLC now owns 2,889 shares of the medical research company’s stock valued at $341,000 after purchasing an additional 157 shares during the last quarter. Institutional investors own 87.41% of the company’s stock.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.